National Bank of Greece S.A (ETE)
Athens Exchange · Greece · prices in EUR · close of 22 Oct 2026
Key indicators
| Last close | EUR 15.91 |
|---|---|
| 52-week range | 12.06 – 18.03 |
| Return, 1 month / 3 months | −8.4% / +3.0% |
| Return, 1 year / 3 years | +21.0% / +229.7% |
| Trend | Above 200-day, below 50-day |
| RSI (14) | 40 |
| Volatility (1 year) | 35.9% |
| Worst drawdown (1 year) | -21.4% |
| Average daily value traded | 51.32M EUR |
| Dividend yield | 3.2% |
Market X-Ray price-based
Five-year price chart navy: price · brown: 200-day average
About the company
National Bank of Greece is a commercial bank based in Athens. It serves individuals, households, businesses and public bodies, mainly in Greece, offering deposit accounts, consumer and mortgage lending, business and corporate finance, payment services and wealth management. The bank also operates through subsidiaries and branches in southeastern Europe and the eastern Mediterranean, and it provides insurance and investment products alongside its core banking services.
National Bank of Greece S.A trades under the code ETE on the Athens Exchange in Greece, with its price quoted in euros (EUR). Our dividend records, which start in 2019, show payments in 4 different calendar years. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.
Summary
National Bank of Greece S.A (ETE) trades on the Athens Exchange in Greece. It last closed at EUR 15.91 on 22 October 2026.
Its price-based Market X-Ray is 68 out of 100 (a fair price profile), ranking 32 of 143 stocks on this exchange. The score describes how the stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is.
Over the last year the price rose 21.0% and over the last three months it rose 3.0%. Returns are price returns, dividends not included.
Fundamental measures (valuation, growth, financial health) are not shown: we do not yet hold financial statements for this market.
The five lenses in numbers each metric is ranked against the other stocks on Athens Exchange
| Lens and metric | Value | Score | Reading |
|---|---|---|---|
| Trend | 75 · Strong | Trading above its long-term averages and near its highs. | |
| Above 200-day average | 5.8% | ||
| From 52-week high | -10.9% | ||
| Momentum | 72 · Strong | Rising faster than most stocks on this exchange. | |
| 3-month return | 3.0% | ||
| 6-month return | 13.5% | ||
| 12-month return, skipping the last month | 32.1% | ||
| Stability (higher is calmer) | 48 · Weak | Volatile, with deep drawdowns. | |
| Volatility, 1 year (lower is calmer) | 35.9% | ||
| Worst drawdown, 1 year (smaller is calmer) | -21.4% | ||
| Liquidity | 99 · Strong | Trades actively. | |
| Average daily value traded | 51.32M EUR | ||
| Zero-volume days | 0.0% | ||
| Income | 49 · Weak | Dividend is small or irregular. | |
| Dividend yield | 3.2% | ||
| Years with dividends | 4 |
Strengths
- Trend: Trading above its long-term averages and near its highs.
- Momentum: Rising faster than most stocks on this exchange.
- Liquidity: Trades actively.
Weak spots
- Stability (higher is calmer): Volatile, with deep drawdowns.
- Income: Dividend is small or irregular.
Returns
| 1 week | −0.8% |
|---|---|
| 1 month | −8.4% |
| 3 months | +3.0% |
| 6 months | +13.5% |
| 1 year | +21.0% |
| 3 years | +229.7% |
| 5 years | +597.3% |
Signals
| 50-day / 200-day average | 16.91 / 15.04 |
|---|---|
| Golden / death cross (60 days) | None |
| New 52-week high | No |
| Bullish RSI divergence | No |
| Average daily range (ATR) | 0.49 |
Technical summary
Recent dividends
| Ex-dividend date | Amount per share |
|---|---|
| 10 Jun 2026 | EUR 0.2940 |
| 10 Nov 2025 | EUR 0.2210 |
| 3 Jun 2025 | EUR 0.4442 |
| 29 Jul 2024 | EUR 0.3643 |
| 14 Dec 2021 | EUR 0.1158 |
How to read this report
Every number comes from end-of-day prices and dividends. The Market X-Ray describes how the stock has traded, ranked against the other stocks on Athens Exchange; it does not measure how healthy or cheap the business is. The fundamental X-Ray (financial health, valuation, growth) needs financial statements, which we hold today for US stocks. See the methodology page. Educational only, not financial advice.